SharpePoint’s ExxonMobil XOM Stock Holding History

SharpePoint’s Portfolio XOM Stock Details XOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Sell	9,450 -293	-3%	-$42.8K	0.96%	44
2025 Q4	$1.17M	Buy	+9,743	New	+$1.13M	0.7%	48
2025 Q3	–	Sell	-10,082	Closed	-$1.09M	–	45
2025 Q2	$1.09M	Sell	10,082 -25	-0.2%	-$2.67K	1.12%	36
2025 Q1	$1.1M	Sell	10,107 -102	-1%	-$11.3K	0.96%	44
2024 Q4	$1.1M	Buy	+10,209	New	+$1.19M	0.99%	32

Other funds holding XOM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SharpePoint's XOM Position: Q1 2026 in Review

SharpePoint reduced its ExxonMobil (XOM) stake by 3% in Q1 2026, selling an estimated $42.8K and leaving 9,450 shares worth $1.6M. The position accounts for 0.96% of the portfolio, ranked #44.

SharpePoint first reported a position in XOM in Q4 2024 and has held it in 5 quarters since. 4,764 funds tracked by Wall St. Rank hold XOM as of Q1 2026.

SharpePoint held 9,450 shares of ExxonMobil worth $1.6M as of Q1 2026.
SharpePoint sold 293 ExxonMobil shares in Q1 2026, an estimated $42.8K.
ExxonMobil made up 0.96% of SharpePoint's portfolio in Q1 2026, its #44 holding.
SharpePoint first reported a position in ExxonMobil in Q4 2024 and has held it in 5 quarters since.
4,764 funds tracked by Wall St. Rank held ExxonMobil as of Q1 2026.

Based on SharpePoint's 13F filing for Q1 2026, filed 5 May 2026.